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The spatial separation of DNA replication and gene transcription in the
nucleus and protein translation in the cytoplasm is a uniform principle of
eukaryotic cells. This compartmentalization imposes a requirement for a
transport network of macromolecules to shuttle these components in and
out of the nucleus. This nucleo-cytoplasmic transport of macromolecules is
critical for both cell physiology and pathology. Consequently, investigating
its regulation and disease-associated alterations can reveal novel therapeu-
tic approaches to fight human diseases, such as cancer or viral infection.
The characterization of the nuclear pore complex, the identification of
transport signals and transport receptors, as well as the characterization of
the Ran system (providing the energy source for efficient cargo transport)
has greatly facilitated our understanding of the components, mechanisms
and regulation of the nucleo-cytoplasmic transport of proteins in our cells.
Here we review this knowledge with a specific emphasis on the selection of
disease-relevant molecular targets for potential therapeutic intervention.
Introduction
The deregulation of the nuclear import and export
machinery is a key marker of various diseases [1,2]. For
example, many tumor suppressor transcription factors
show cytoplasmic sequestration ablating their nuclear
functions allowing, for example, uncontrolled cell divi-
sion [3]. The aberrant localization of onco-proteins can
also lead to their inadequate activation. Examples of
aberrant nucleo-cytoplasmic shuttling that correlates
with tumor formation, progression or resistance to
treatment include p53, FOXO3a, p27, BRCA1, APC,
nucleophosmin retinoblastoma, b-catenin, nuclear fac-
tor-jB (NF-jB), survivin and cyclin D1 [3–5]. Beyond
cancer, many viruses including human HIV-1, influenza
A, dengue, respiratory syncytial virus, rabies, Rift Val-
ley fever virus and Venezuelan equine encephalitis virus
rely on the transport of specific viral proteins into the
host cell nucleus to perturb the anti-viral response.
Therefore, inhibiting the nuclear trafficking of viral pro-
teins has been proposed as a viable therapeutic strategy
[6]. Over the last decade, the research community has
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acquired a critical mass of significant knowledge on the
constituents of the nuclear transport machinery. The
emerging picture, while intriguingly complex, suggests
that there is an availability of a broad range of
molecular targets enabling specific therapeutic interven-
tions. The transport of cargo proteins is mediated by
several distinct types of transport signals that are recog-
nized by specific transport receptors or via a variety of
adaptor proteins. These transport receptors can then
interact with components of the nuclear pore complex
(NPC) and with the Ras family GTPase Ran. Many of
the steps within this process have the potential to be
therapeutically targeted for innovative anti-cancer and
anti-viral therapies.
The nuclear envelope and the nuclear
pore complex
The nucleus is surrounded by an envelope composed of
two phospholipidic membranes: an outer and an inner
nuclear membrane that are 30 nm apart. The nuclear
envelope (NE) provides a much stronger physical bar-
rier than the single cordon of the plasma membrane.
The outer nuclear membrane is continuous with the
endoplasmic reticulum [7], whereas the inner nuclear
membrane is associated with a network of intermediate
filaments composed of lamin called the nuclear lamina.
This acts as a site of attachment for chromosomes and
as a shield for the nucleus [8]. The NE functions like a
selectively permeable barrier allowing macromolecules
to move between the nucleus and the cytoplasm via a
gatekeeper, the NPC. The NPC is a huge protein
complex that fuses the internal and external nuclear
membrane to form an aqueous channel (Fig. 1). The
NPC is cylindrical measuring 100–150 nm in diameter
and 50–70 nm in thickness [9] and is broadly conserved
in eukaryotes [10,11]. The molecular mass of the NPC is
approximately 125 000 kDa and the number of NPCs
per nucleus is highly variable among organisms. The
average number of NPCs within a vertebrate cell is
between 2000 and 5000 [12] and has been extensively
studied by electron microscopy (EM). In particular the
development of cryo-EM and cryo-electron tomography
(cryo-ET) allowed structural preservation to be
enhanced and purification steps to be minimized and as
a consequence the detailed and artifact-free analysis of
the NPC [12–15]. These EM-based studies revealed a
highly modular and dynamic structure with a dough-
nut-shaped central core with an eightfold rotational
symmetry [16]. A central channel is surrounded by three
ring-like structures, namely the cytoplasmic ring, the
central spoke ring and the nuclear ring. Attached to this
core structure are eight protein filaments on the cyto-
plasmic side and eight protein filaments on the nuclear
side that converge to a ring-like structure termed the
nuclear basket.
The NPC is composed of 30 different proteins
termed nucleoporins (Nups) [17] that are organized
into several sub-complexes, each of which is present in
multiple copies, resulting in approximately 500–1000
individual proteins in the fully assembled NPC [18].
The transport of salts, nucleotides, small molecules/
proteins and components required for the syntheses of
DNA and RNA occurs passively by diffusion through
the NPC. In contrast, proteins larger than 40–65 kDa
must be transported into the nucleus through the NPC
with the assistance of transport receptors. These recep-
tors recognize the transport signals that are present on
cargo proteins allowing their import (reviewed in [19]).
The key function of the NPC is to form a diffusion
barrier between the cytoplasm and the nuclear com-
partment and to enable the nucleo-cytoplasmic traffic
of macromolecules. In addition, the NPC is also
involved in other nuclear processes that include DNA
repair [20], the cell cycle [21], chromatin organization
[22], transcription regulation [23,24], epigenetic mem-
ory [25] and RNA maturation and quality control [26].
Nucleoporin proteins
Despite its enormous dimensions, the NPC is built
from a surprisingly small number of proteins called
nucleoporins (Nups) [18]. The NPC displays a high
degree of internal symmetry and can be divided into a
symmetric part, enclosed in the nuclear membrane,
and an asymmetric part, with extensions into the
nucleus or cytoplasm (Fig. 1). Nups from the symmet-
ric part of the NPC are generally classified into three
categories: membrane-anchored (POMs, part of the
nuclear envelope), scaffold (coat Nups and adaptor
Nups) and channel (barrier Nups). Each category has
unique structural features that are essential to execute
specific functions. The Nups that form the asymmetric
part of the NPC are called nuclear basket Nups and
cytoplasmic filament Nups.
Membrane Nups
Membrane Nups (POMs) anchor the symmetric part
of the NPC to the pore membrane where the inner
and outer nuclear membranes fuse to form the nuclear
pore binding the assembly complex to the NE. Mem-
brane Nups contain transmembrane a-helices that
allow the protein to anchor onto the membrane while
large regions extend toward the luminal and pore sides
of the membrane [27,28].
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Scaffold Nups
The scaffold Nups (coat Nups and adaptor Nups)
form the skeleton of the NPC connecting the mem-
brane Nups to the barrier Nups. The scaffold Nups
contain mainly a-solenoid and b-propeller folds and
are classified into outer ring Nups, inner ring Nups
and linker Nups according to their location and func-
tion. The high flexibility of the outer ring Nup compo-
nents allows for conformational changes of the
scaffold that enable large cargo to pass through the
central channel [29].
Barrier Nups
Barrier Nups (channel Nups) are phenylalanineglycine
Nups (FG-Nups) and form the innermost cylindrical
layer that acts as a selective gatekeeper for nuclear
transport regulation. FG-Nups contain multiple
stretches of FG sequences that form intrinsically
disordered regions. These motifs are present in about
one-third of Nups forming an unstructured meshwork
lining the central channel. The tentacle-like structures
provide several low affinity, high specificity interac-
tions with transport receptors that escort cargo pro-
teins through the nuclear pore. Collectively, FG-rich
regions build the diffusion barrier of the NPC.
Asymmetric Nups
Asymmetric Nups (formed by nuclear basket Nups
and cytoplasmic filament Nups) are key components in
establishing the directionality of the nucleo-cytoplas-
A 
C
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Fig. 1. Overall structure and molecular
composition of the nuclear pore
complexes (NPCs). (A) General structural
features of the NPC. (B) A schematic
model of the NPC. In this model, the NPC
is divided into several groups according to
their location and structural characteristics.
The symmetrical core is composed of
membrane-anchored POMS
(transmembrane ring), channel Nups
(central FG-Nups) and scaffold Nups
composed by adaptor Nups (inner and
linker Nups) and coat Nups (outer ring).
Asymmetric parts of the pore are the
nuclear FG-Nups and the basket plus the
cytoplasmic FG-Nups and filaments.
(C) The yeast and vertebrate homolog
Nups that are known to constitute each
NPC substructure are listed. Symmetric
Nups are equally distributed on the
cytoplasmic and nucleoplasmic parts of
the NPC and form the core region.
Asymmetric Nups form the nuclear basket
and the cytoplasmic filaments. They serve
as docking sites for transport factors and
include associated mRNA export factors.
See the main text for more information.
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mic transport process. These structures mediate spe-
cific interactions with transport complexes and several
asymmetric Nups that contain FG repeats serving as
binding sites with important roles in cargo–NPC inter-
actions.
The transport signals
For nuclear import and export, macromolecules gener-
ally require specific transport signals, namely a nuclear
localization signal (NLS) or a nuclear export signal
(NES) (Fig. 2). Soluble transport receptors of the
karyopherin family of proteins (known as importins
and exportins) recognize these sequences within macro-
molecules. NLS and NES can be defined as sequences
within proteins that are necessary and sufficient for
their import/export (summarized in Table 1). These
sequences bind transport receptors either directly or
via adaptor molecules and enable the release of the
transport complex at the end of the translocation
process [30]. The transport signals that interact with
importin-a (Imp-a), importin-b (Imp-b), CRM1 (chro-
mosome region maintenance 1, also known as expor-
tin1 or Xpo1) and transportin-1 (also known as
karyopherin-b2) are well described but they remain to
be determined for the other 16 human karyopherin-bs
[31–35]. The known NLSs can be classified into either
classical NLSs or non-classical NLSs. The classical
NLSs can be further divided into monopartite or
bipartite NLSs. The non-classical NLSs include pro-
line-tyrosine NLSs (PY-NLSs) that allow the cargo
protein to bind to karyopherin-b2 that mediates the
direct interaction with Imp-b. For nuclear export, the
leucine-rich NES (recognized by CRM1) is the most
extensively characterized export signal while the struc-
ture of the CRM1-snurportin1 and RanGTP complex
has been elucidated [36,37].
Classical NLSs
The first nuclear transport signals were described in the
SV40 large T antigen and nucleoplasmin in the early
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Fig. 2. Schematic overview of Ran-dependent nucleo-cytoplasmic transport. Nuclear export. CRM1 exports a great part of NES-containing
protein. Nuclear import. Importin-a (Imp-a)/importin-b (Imp-b) heterodimer (designated as a and b) and karyopherin-b2 mediate the import of
NLS-containing proteins. See the main text for details.
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1980s comprising a short lysine-rich sequence classified
as classical NLSs [31,38]. These bind the armadillo
(ARM) domain in the C terminus of Imp-a. The adap-
tor protein Imp-a also binds the transport receptor
Imp-b through its N-terminal aIBB domain forming a
ternary complex [39]. The small size and relatively
simple sequence patterns of these basic NLSs have
facilitated identification of similar signals in many pro-
teins. The classical NLSs contain one or two clusters of
positively charged amino acids, typically lysine or argi-
nine, and are divided into two classes, monopartite and
bipartite classical NLSs [40]. The monopartite classical
NLS is a short and highly basic signal. The two
stretches of basic amino acids within a bipartite classi-
cal NLS are separated by a linker region that is usually
10–12 residues long, although longer linker sequences
have been reported [41]. In addition, several atypical
NLSs that bind to classical NLS binding sites in Imp-a
have been characterized, including the hydrophobic
NLS from phospholipid scramblase 1 [40].
Non-classical NLSs
Some cargo proteins bypass the requirement for an
adaptor protein and bind directly to transport recep-
tors through non-classical NLSs. Proteins that are
directly recognized by Imp-b include ribosomal pro-
teins, CREB, the human immunodeficiency virus
(HIV) Rev and Tat, SREBP-2, the human T-cell leuke-
mia virus type 1 (HTLV-1) protein Rex, PTHrP, cyclin
B1, Smad3, TRF and SRY [40]. In contrast to the
interaction between classical NLS and Imp-a, proteins
that bind to Imp-b directly do not obey strict rules
and the NLSs that confer Imp-b recognition vary sig-
nificantly in both size and charge [40].
Many proteins that are imported into the nucleus
can bind directly to the transport receptor transportin-
1. Common characteristics between the apparently dis-
parate signals recognized by transportin-1 were
described unifying them into a new class of NLS
termed PY-NLS [34]. The consensus motif of PY-NLS
consists of a loose N-terminal hydrophobic motif, a
central arginine residue and a C-terminal PY sequence
[42]. The physical rules that describe the PY-NLSs as
structurally disordered in free cargoes, positively
charged and with weak consensus motifs predicted
approximately 100 candidate transportin-1 cargoes
[34]. Several of these have been confirmed experimen-
tally [34,43,44]. Interestingly, arginine–glycine-rich
NLSs known as RG-NLSs in the yeast proteins Hrp1
and Nab2 and the 38 amino acid long NLS of the
hnRNP A1 protein, designated M9, were also shown
to have the same characteristics as the PY-NLS
[42,45]. Recently other non-classical NLSs such as the
extensive coiled-coil domain of STAT5a [46] have been
characterized. Furthermore, a number of proteins have
been identified that contain both classical and non-
classical NLS motifs that can interact directly with
both Imp-a and Imp-b family members.
Leucine-rich NESs containing cargoes
The first signals that direct the nuclear export of a
protein were identified in HIV Rev and protein kinase
Table 1. Examples of different types of nuclear transport signals.
Amino acid sequence Protein Type of signal References
PKKKRKV SV40 T antigen Classical NLS [33]
KRx{10}KKKL Nucleoplasmin Bipartite NLS [31,33]
VRILESWFAKNIENPYLDT Mata2 Polar/nonpolar residues NLS [196]
PAAKRVKLD c-Myc cMyc-NLS [197]
YNDFGNYNNSSNFGPMKGG
NFGGRSSGPYGGGGQY
hnRNP A1 (M9 sequence
hydrophobic subclasses)
hPY-NLS [198]
KVSRRG-GHQNSYKPY hnRNP D (basic enriched) bPY-NLS [45]
RQARRNRRRRWR VIH Rev protein Arginine-rich NLS [199]
DNSQRFTQRGGGAVGKNRRG
GRGGNRGGRNNNSTRFNPLAK
Nab2p Arginine/glycine-rich NLS [200]
KTPGKKKKGK Parathyroid hormone-
related protein (PTHrP)
Lysine-rich-NLS [201]
QDLNSTAAPHPRLSQYKS
KYSSLEQSERRRRL
Snurportin1 UsnRNPs-NLS [202]
LPPLERLTL HIV Rev Hydrophobic-NES [32]
LALKLAGLKI PKI NES [35,203]
LCQAFSDVIL Cyclin B1 NES
LQKKLEELEL MAPKK NES [204]
LAEMLEDLHI NMD3 NES [77]
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inhibitor A [32,35]. The consensus sequence for NES is
/1-X(2–3)-/2-X(2–3)-/3-X-/4 (where / represents one
of the hydrophobic residues L, V, I, F or M, and X
can be any amino acid but preferentially is charged,
polar or a small amino acid) [47–49].
More complex export signatures incorporate the
three-dimensional features of the whole protein that
are recognized and targeted for export [50,51]. Proteins
containing these NESs are recognized and exported by
CRM1 [52–55] (Fig. 2). G€uttler et al. showed that
CRM1 contains five pockets for binding the conserved
hydrophobic residues of NESs. Accordingly, a struc-
ture-based NES consensus with an additional hydro-
phobic position (five instead of four) has been
proposed [56]. Kosugi et al. generated a large number
of NES peptides in a random peptide library screen
and delineated multiple distinct consensus sequences
that described more than 80% of known functional
NESs [57]. A predictor, NESsential, that uses sequence
derived meta-features, such as predicted disorder and
solvent accessibility, in addition to a primary sequence
that can identify promising NES-containing candidate
proteins [58,59], http://validness.ym.edu.tw/index.php.
Other recently developed NES predictor tools include
WREGEX, which uses position-specific scoring matrices
for motif prediction [60], and NESMAPPER (http://source-
forge.net/projects/nesmapper), which has been devel-
oped based on the activity profile of all classes of
NESs [61].
Nuclear transport receptors
Proteins larger than 40 kDa are transported through
the NPC by soluble nuclear transport receptors
(NTRs). NTRs continuously shuttle between the
nucleus and the cytoplasm, bind their cargo on one
side of the nucleus and release it on the other side.
The majority of the nuclear-cytoplasmic transport
receptors are members of the b-karyopherin protein
family with each member recognizing a unique group
of cargo proteins or RNAs (summarized in Table 2)
[62]. There are 22 putative members of the karyopher-
in family in humans [63] that share only modest
sequence homology with the greatest homology noted
within their Ran-binding domain [64]. A specific archi-
tecture within the karyopherin family is the tandem
HEAT repeat fold formed by anti-parallel helices that
are linked by a short intra-repeat loop [65]. These
repetitive structures are inherently flexible and contrib-
ute substantially to Ran-controlled cargo recognition
and cargo release [66]. Karyopherin-b proteins can
either directly or indirectly, through adaptors, interact
with their cargo. In addition there are six homologs of
adaptor proteins that belong to the Imp-a protein fam-
ily that have been identified in humans which adds a
further level of complexity to this process [67]. For
example, Imp-b mediated nuclear import of the uri-
dine-rich small nuclear RNPs involves a different
adaptor protein called snuportin-1 and, as in the case
of Imp-a, snuportin-1 binds Imp-b through an IBB
domain. The karyopherin-b proteins are multi-domain
transport factors that contain a cargo binding domain,
an NPC binding domain [68] and a binding domain
for the small Ras-like GTPase Ran [69,70]. Family
members contain both import and export receptors;
however, only a few of them have been functionally
characterized in higher eukaryotes (indicated in
Table 2).
Import receptors
A protein that contains a classical NLS is bound by
the NLS binding pocket formed by the armadillo
repeats within the Imp-a adaptor protein. The trans-
port receptor Imp-b binds to Imp-a and then targets
the NLS-containing protein into and through the
NPC. Intriguingly, Imp-b has been shown to contain
two binding sites for FG-rich motifs that are located
away from the cargo binding site [71]. Most karyoph-
erin-b proteins do not rely on adaptors to bind to car-
goes as they can directly interact with basic NLSs of
core histones and ribosomal proteins or arginine–gly-
cine-rich NLSs of some RNA binding proteins.
Export receptors
CRM1 (chromosome region maintenance 1)
The most extensively characterized export receptor is
chromosome region maintenance 1 (CRM1), a member
of the karyopherin-b family of receptor proteins.
CRM1 exports proteins that contain leucine-rich NESs
from the nucleus into the cytoplasm [53,55]. CRM1
has 20 HEAT domains that allow RanGTP to bind.
Cargo binding takes place outside of this HEAT
domain ring in a hydrophobic cleft producing a gen-
eric NES docking site [56]. CRM1 recognizes NESs
that are present in a large range of proteins that are
structurally unrelated [72]. CRM1 can also be
recruited by adaptor molecules in situations where it
does not bind directly to a protein that is to be
exported from the nucleus (e.g. Exp5 cooperates with
CRM1 to export large ribosomal subunits [73]).
CRM1 also participates in the export of the 40s and
60s pre-ribosomal subunits as well as essential RNPs
[74–77]. With two adaptors [the Cap binding complex
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(CBC) complex and PHAX] CRM1 is also essential
for the maturation of the spliceosomal U snRNPs
[78,79]. Furthermore, CRM1 actively maintains the
exclusive cytoplasmic localization of RanBP1, Ran-
GAP and other translation factors that contribute to
the identity of the nuclear compartment [80–83].
Another key function of CRM1 is its role in SPN1
recycling (an adaptor for U snRNPs) back to the cyto-
plasm [51]. Intriguingly, overexpression of CRM1 has
been reported in various tumor types and has been
Table 2. Transport receptors and cargoes.
Vertebrate karyopherins
Saccharomyces
cerevisiae karyopherins Cargoes (selection) vertebrate (V) yeast (Y)
Imp-b/Kapb1 Kap95 Classical NLS via Imp-a; cyclin B1; snurportin1; SRY; PTHrP; CREB, AP-1,
TRF1, Smad3; SREBP-2; HTLV-1 Rex, HIV-1 Tat, HIV-1 Rev; NF-YA;
adenovirus core protein pVII; aristaless/arx; cJun; H1; HPV16E6; H1; H2A;
H2B; H3; H4; rPL23a, rPS7, rPL5, rPL18a, rPL6, rPL4; PP2A (PR65)
Kapb2 (Transportin/
Transportin-2)
Kap104 (V) PY-NLS cargoes; PQBP-1, YBP1, PABP2, EWS, FUS, SAM68, hnRNP M,
hnRNP A1, hnRNP A0, hnRNP A2, hnRNP A3, hnRNP D, hnRNP F, JKTP-1,
TAP (NXF1), HuR, HEXIM1, RB15B, Clk3, WBS16, Cyclin T1, TAFII68,
CPSF6, HCC1, ETLE; tfg2p non PY-NLS cargoes: TAFI48; NPM-ALK, SRP19;
H2A; H2B; H3; H4; c-Jun; rPL23a, rPS7, rPL5; adenovirus core protein pVII;
HIV-1 Rev; HPV16 E6, HPV16 L2, HPV18 L2 (Y) Nab2p; Hrp1p; Tfg2p
Importin-5 (Kapb3 or
RanBP5)
Kap121 (Pse1) (V) p60TRP;Rag-2; PGC7/Stella; apolipoprotein A-I; influenza A PB1-PA;
HPV18 L2; HPV16 L2; CDK5 activator p35; TAFI48, c-Jun; HIV-1 Rev;
rPL23a, rPS7, rPL5, rPS3a; H2A; H2B; H3; H4 (Y) Aft1p; Asr1p; Egd1p;
Nop1p, Nup53p; Pdr1p; Pho4p; Sas2p; Sof1p; Spo12p; Ste12p; Yap1p;
Yra1p; secondary pathway for histones, ribosomal proteins, Ho, SRP, TBP
Importin-4 (RanBP4) Kap123 (V) Vitamin D receptor, TP2, HIF1-a, rPS3a (Y) Egd1p; H3 (Hht2p, H4 (Hhf2p);
Sas2p; SRP; Rpl25p, Rp10a, Rps1p, Rpl4p, Rpl15p, Rpl16p, Rpl18p,Rpl25p,
Rpl41p; secondary pathway for Asr1p, Asf1p, H2A, H2B, Htz1p, Yap1p,
Yra1p, TBP
Importin-9 Kap114 (V) Hepatocellular carcinoma associated protein, HSP27, rPS3, rPS9, rPL19,
rPL18a, rPS7, rPL6, rPL4; c-Jun; H2A, H2B, H3, H4; aristaless (Arx); PP2A
(PR65); (Y) H2A (Hta1p), H2B (Htb1p, Nap1p, TBP (Spt15p); TFIIB Sua7p);
rfp1; secondary pathway for Asr1p
Importin-7 Kap119 (Nmd5) (V) Proline-rich homeodomain; EZI; RK-2, MEK1, Smad3; HIV-1 integrase;
CDK5 activator p35; HIF1-a; c-Jun; glucocorticoid receptor;HIV-1 Rev;
rPL23a; rPS7; rPL5; H2A, H2B, H3, H4; Imp-b/-7 heterodimer: H1; HIV-1
integrase, adenovirus core protein pVII; rPL6, rPL4, rPS3a; (Y) Crz1p; Gal4p;
Hog1p; Ssa4p; TFIIS (Dst1p), Rpf1p; secondary pathway for histones H3 and
H4
Importin-8 (RanBP8) Kap108 (Sxm1) (V) Ago2; Smad4, Smad1; NPM-ALK; SRP19; (Y) Lhp1p, Pab1p, Rpl16p,
Rpl25p, Rpl34p; secondary pathway for Ho, histones H3 and H4
Transportin-SR
(-SR2/-3/TNPO3)
Kap111 (Mtr10) (V) ASF/SF2, SC35, TRA2a, TRA2b; HPV E2, RBM4, ALEX3, BAB71287,
BAP1, MLF2, ODF2; dASF, dSC35, d9G8, Rbp1, B52, RSF1; HIV1 IN; (Y)
Gbp2p; Hrb1p; Npl3p; tRNAs
– Kap122 (Pdr6p) (Y) Imports sc-cargo – Toa1 and Toa2, TFIIA
Importin-13 – NF-YB/NF-YC; NC2a/NC2b; Myopodin, hUBC9, elF1A Y14-Mago;
glucocorticoid receptor CHRAC-15/CHRAC-17, p12/CHRAC-17; PAX6, Pax3,
Crx; Aristaless (Arx); rPL5; histone fold heterodimers
CRM1 (Exportin-1) CRM1 (Xpo1/Kap124p) Leu-rich NES cargoes; HIV genomic RNA; m7G- capped UsnRNAs; 40S and
60S pre-ribosomal subunits via NMD3 adaptor; snurportin1 (SPN1)
CAS (Exportin-2) Kap109 (Cse1) Imp-as (Y) Kap60/Srp1
Exportin-4/
Bidirectional NTRs
– Sox-2, SRY; eIF5A, Smad3
Exportin-5 Kap142 (Msn5) tRNA, eEF1A (via aa-tRNA); dsRNA-binding proteins (via dsRNA); pre-miRNAs;
60S pre-ribosomal subunits
Exportin-6 – Actin-profilin complexes
Exportin-7 (RanBP16) – p50-RhoGAP, 14-3-3-r
Exportin-t (Xpo-t) Kap127 (Los1) tRNA
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correlated with poor prognosis and resistance to ther-
apy [4,5]. In addition CRM1 is hijacked during infec-
tion by many viruses [32,84–86].
Other exportins
In addition to CRM1, a number of other alternative
export receptors have been characterized. Exportin 2
recycles Imp-a from the nucleus into the cytoplasm
allowing Imp-a to mediate another round of nuclear
import if required [87–89]. Together with the adaptor
STRADa exportin 7 regulates the distribution of
LKB1 kinase [90] and regulates the leakage of Rho-
GAP1 and 14-3-3-r into the nucleus [91]. Exportins
are also dedicated to RNA transit. For example, ex-
portin-t is dedicated to export fully mature tRNA with
the 50- and 30-ends correctly processed [92–95]. A sec-
ond tRNA (alone or with eEF1A) exporter is exportin
5 which displays a different binding specificity com-
pared to exportin-t [80,96]. Exportin 5 also exports
double strand RNA, pre-miRNAs [97–99] and cooper-
ates with CRM1 as described previously. Exportin 4
exports eIF5A and Smad3 but can also act as an
importin for Sox-type transcription factors [100,101].
Importin 13, despite its namesake, also demonstrates a
bi-directional transit capability directing eIF1A nuclear
export and the import of the heterodimer component
of the exon junction complex Mago-Y14 [102,103].
Alternative nuclear transport
pathways
While most proteins are transported through the NPC
by conventional karyopherin-b mediated mechanisms,
alternative nuclear transport pathways have been
described for a number of proteins. These karyopher-
in-b-independent pathways include transport by alter-
native carriers such as the calcium-binding proteins
calmodulin and calreticulin and translocation that
seems to be mediated by direct interaction with NPC
components, independent of carrier molecules. Impor-
tantly, many proteins are transported by more than
one mechanism. It has been suggested that these seem-
ingly redundant pathways may ensure the maintenance
of cellular functions under conditions in which one
pathway is inhibited [104]. Calmodulin has been shown
to facilitate the nuclear import of the transcription fac-
tors SRY and SOX9 by binding to specific sequences
in a way similar to NLS binding by karyopherin-b
[105]. The nuclear import of these transcription factors
is regulated by calcium. Similarly, calreticulin exports
the glucocorticoid receptor from the nucleus in a cal-
cium-dependent manner [106]. In addition, calreticulin
is involved in the nuclear export of thyroid hormone
receptor a1 and viral proteins [107–109].
Some proteins can enter the nucleus without requir-
ing receptor proteins and there is growing evidence
that receptor-independent nuclear import can be medi-
ated by the direct binding of the transport cargo to
FG-containing Nups. It has been suggested that pro-
teins with armadillo repeats such as b-catenin, that are
structurally related to karyopherin transport receptors,
can directly bind to the NPC and are imported into
the nucleus independently of conventional NTRs of
the karyopherin-b type. Other proteins such as the
tumor suppressor proteins SMAD3 and 4 and the
transcription factor PU.1 utilize direct binding to FG-
Nups to cross the NPC. Conversely, some proteins can
be transported through their interaction with proteins
that contain a functional NLS known as a ‘piggyback’
mechanism. Recently, Speese et al. reported a novel
NPC-independent mechanism for the nuclear export of
RNP by nuclear envelope budding akin to nuclear
egress of herpes-type viruses [110]. During this mecha-
nism, RNP granules bud into the perinuclear space in
a manner dependent on lamin C.
The Ran system
The nucleo-cytoplasmic transport process mediated by
members of the karyopherin protein family requires
metabolic energy. The loading and unloading of trans-
port receptors with cargo molecules is controlled by
the small Ras-like GTPase Ran and requires GTP
hydrolysis [111]. Ran is a 25 kDa protein that exists in
two different nucleotide-bound states: RanGDP and
RanGTP [112,113]. Ran hydrolyzes GTP very slowly
and interacts with regulatory proteins including Ran-
GAP1 (Ran GTPase activating protein 1) and RanBP1
that significantly increase GTP hydrolysis by Ran
[114]. Conversely, the Ran regulatory protein RanGTP
exchange factor (RanGEF, also termed RCC1 in
human cells) accelerates the exchange of nucleotides
restoring the pool of the RanGTP. RanGAP1 is exclu-
sively cytoplasmic [115] and RanBP1 is predominantly
localized in the cytoplasm [116] whereas RanGEF is
nuclear. As a consequence of this strict nuclear locali-
zation of RanGEF and cytoplasmic RanGAP1, Ran
in complex with GTP is localized mostly in the nucleus
and RanGDP (Ran in complex with GDP) in the
cytoplasm [62]. This RanGTP gradient provides direc-
tionality to nuclear-cytoplasmic transport because
importins and exportins differ in the way they utilize
the RanGTP gradient [117]. Import complexes are dis-
sociated by RanGTP binding in contrast to export
complexes which are formed by association with
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RanGTP. Both importins and exportins bind RanGTP
directly [52,118,119] and use the metabolic energy sup-
plied by the RanGTPase system for directional trans-
port [120,121]. Importins bind their cargo at low
RanGTP level (in the cytoplasm) and traverse the
NPC as dimeric complexes transporting cargo (Fig. 2)
[118,119]. Exportins act in an opposite manner,
recruiting their cargo at high RanGTP levels in the
nucleus (Fig. 2) [84,88]. The RanGTP-exportin-cargo
complex crosses the NPC into the cytoplasm where it
disassembles following GTPase activation releasing the
transported cargo. The free export in translocates back
into the nucleus to mediate another round of export.
Trafficking of macromolecules
through the NPC
A number of models have been proposed to describe
the molecular mechanism of selective gating through
the NPC. The polymer brush model suggests that
movements of the unfolded FG-Nups sweep away
macromolecules [11,122,123]. Conversely, the collapse
model, based on atomic force microscopy data
[124,125], suggests that regions of FG repeats may col-
lapse following the binding of transport factors. These
transport factors would open up their own passage
through the central tube when they pass the meshwork
of FG repeats. The ‘hydrophobic gel’ model [126], also
called ‘saturated model’ [127,128], proposed that the
phenylalanines in the FG repeat regions are cross-
linked with each other and form a dense gel of FG
repeat filaments. Transport factors bind to these FG
repeats, dissolve the crosslinks and facilitate passage
through the nuclear pore. Another model suggested
that the FG repeat regions form a layer coating the
inner walls of the central tube where non-binding mol-
ecules can only pass through the narrow FG-Nup-free
middle and where the transport factors enter this layer
through binding giving them full access to the tube
volume [129]. Melcak et al. proposed a model of pore
dilatation by intermolecular sliding of Nup58/45 tetra-
mers to adjust the diameter of the transport channel
for the passage of cargo [130].
Nuclear import
The recognition of NLSs by Imp-a and heterodimer-
ization with Imp-b initiates the process of nuclear
import. The import complex, consisting of the cargo
protein and the Imp-a/b complex, localizes to the
nuclear envelope, binds RanGDP and docks at the
nuclear pore. The Imp-a/b complex mediates the bind-
ing to and translocation through the NPC. Once trans-
location through the pore is executed, dissociation of
the import complex is stimulated by RanGTP in the
nucleus. Importin-a is recycled back to the cytoplasm
through the nuclear exporter CAS, whereas Imp-b is
separately transported back to the cytoplasm together
with RanGTP. RanGAP1-facilitated GTP hydrolysis
of Ran on the cytoplasmic side causes the release of
Imp-b for the next cycle.
Nuclear export
The process of nuclear export is carried out according
to principles which are analogous to those of nuclear
import, using specific nuclear export receptors like
CRM1 that recognize NES sequences on cargo pro-
teins [131,132]. The affinity of CRM1 for most NESs
is low and formation of the export complex is pro-
moted by RanBP3 which links CRM1 to the chroma-
tin binding protein RCC1 [133,134] and increases the
active concentration of RanGTP. This promotes the
affinity of the NES cargo for the export receptor
[135,136]. This complex moves through the NPC via
the interaction with FG repeat proteins [137]. Within
the cytoplasm, the CRM1 complex binds to the cyto-
plasmic filament complex (Nup88, Nup214 and
Nup358 [84,138–141]) and interacts with RanGAP
causing the hydrolysis of GTP which promotes the
dissociation of the protein complex. Following this dis-
sociation, the cargo is released in the cytoplasm
[36,142].
Export of RNAs
RNAs transcribed in the nucleus have to be exported,
either to fulfill their function in protein synthesis or to
mature into functional particles [143]. The pre-mRNA
is processed and packaged into messenger ribonucleo-
protein (mRNP) complexes to be exported through
bulk or specific export. The majority of poly-A tran-
scripts are exported via the non-karyopherin heterodi-
mer Nxf1/Nxt1 independently of the RanGTP
gradient. Conversely, a specific subset of endogenous
transcripts is exported from the nucleus via CRM1.
For efficient export, RNAs must undergo processing
that includes splicing, 30-end formation of the poly-A
tail and the addition of a methyl-7-guanosine (m7G)
cap structure to their 50-ends [144–146]. For the major-
ity of transcripts, the m7G cap recruits the CBC,
which then activates export factors that allow the
export mRNPs to bind to the NPC and traverse the
hydrophobic central channel. Nxf1 (also known as
TAP) [147]) is the major driver of interaction between
the export mRNP and the NPC. The Nxf1/Nxt1 hete-
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rodimer is recruited to the mRNP via the transcrip-
tion-export (TREX) complex [79,144,145,
148–150]. The TREX complex consists of UAP56,
REF/a Aly, CIP29 and THO multi-subunit complex
composed of THOC1/Hpr1, hTho2, THOC5, THOC6,
THOC7 and Tex1 [144,151–153]. REF/Aly and THO
complexes promote the interaction of cargo mRNAs
with the Nxf1 receptor [144,151] that associates
mRNPs with the nuclear basket via the ribonucleic
acid export protein Rae1 and Nup98 to permit passage
through the central channel (Fig. 2) [154,155]. At the
cytoplasmic face, the cargo mRNPs are released and
the export factors are recycled. RanBP2 associates
with Nup88 and Nup214 [141] and plays a very impor-
tant role in cargo release and recycling after bulk
mRNA export.
An alternative to the Nxf1-driven export pathway
involves the serine- and arginine-rich SR proteins
SRp20 and 9G8 that mediate the export of H2a
mRNA and of some spliced transcripts [156,157].
Although the majority of mRNAs use the Nxf1 recep-
tor to cross the NPC, subsets of transcripts are
exported via the general CRM1 pathway. Addition-
ally, through protein cofactors, CRM1 is involved in
the export of specific types of mRNAs, small nuclear
RNAs (U snRNAs) and ribosomal RNAs. CRM1
does not bind RNA directly but via NES-containing
adaptor proteins that bind to RNA or other RNA
binding proteins [148]. Once this step is completed,
CRM1–cargo complexes dissociate, permitting the
RNA to enter the cytoplasm and to recycle export
factors [148]. As in bulk mRNA export, Nup88,
Nup214 and RanBP2 play critical roles in the recy-
cling and release steps for CRM1-dependent export
[138,158].
Regulation of the nucleo-cytoplasmic trafficking
The nucleo-cytoplasmic transport processes are regu-
lated by cellular signaling systems via cargo protein
modification(s) and the transport machinery, including
the transport receptors, the NPC and the Ran system.
Indeed targeting nucleo-cytoplasmic transport has
directed the development of new exciting therapeutic
avenues to treat cancers that display aberrant protein
subcellular localization [159,160].
Modification of the cargo proteins
Importin-NLS/exportin-NES interactions can be
modulated by conformational changes in both NLS/
NES regions and in the substrate binding site of
karyopherins [161]. In some cases the three-dimen-
sional structure of a protein masks its own transport
signal as in the case of p105 [161], the precursor p50
subunit of NF-jB. Upon stimulation, p105 is phos-
phorylated, the C-terminal part of the protein is
degraded and the NLS becomes accessible allowing
the p50 protein to be recognized by the Imp-a/Imp-b
complex [162]. Furthermore, phosphorylation within
or close to the NLS/NES can promote intramolecu-
lar masking. In the case of Hog1p (high osmolarity
glycerol pathway-signaling protein) phosphorylation
at Thr174 and Tyr176 renders Hog1p-NES inaccessi-
ble for binding to CRM1 and prevents its export
from the nucleus [163]. Similarly NF-AT2 (nuclear
factor of activated T cell 2) contains two NLSs that
can be masked by phosphorylation at a low calcium
concentration. Following a calcium concentration
increase, calcineurin is dephosphorylated and NF-
AT2 is imported into the nucleus [164–166]. In the
canonical NF-jB pathway, I-jB masks the NLS
sequence of NF-jB p65 [167]. In resting conditions,
I-jB is phosphorylated, ubiquitinated and degraded
by proteasome resulting in NLS unmasking and NF-
jB p65 nuclear import [168,169]. One of the multiple
regulatory mechanisms of p53 is its homo-tetramer-
ization that masks one of its NES sequences. Disso-
ciation of this tetramer is required for its nuclear
export [170]. Binding of proteins to RNA and DNA
can also modulate the intermolecular masking of
localization signal. For example, the NLS of the Rev
protein, implicated in HIV mRNA translocation, is
masked when Rev is linked to mRNA and recycling
of Rev is possible only after release of the trans-
ported mRNA [171]. Conversely, nucleo-cytoplasmic
transport can be enhanced by phosphorylation of
SV40 virus large T antigen [172] or Pho4 factor
[173] increasing the affinity of their NLS/NES signals
to the corresponding karyopherin receptors [172].
Viral regulation of nucleo-cytoplasmic trafficking
Many viruses have evolved elegant strategies to exploit
the host nucleo-cytoplasmic transport pathways to
evade the cellular anti-viral response or to facilitate
viral replication. Some viruses such as the vesicular
stomatitis virus interact with Nups to inhibit the
export of host mRNAs that encode anti-viral factors
and make the translation machinery available for
expression of viral mRNAs [174]. Similarly, the
ICP27 protein of herpes simplex virus interacts with
Nup62 and blocks nuclear import of proteins via
Imp-a/b1 and Imp-b2 pathways [175,176]. Conversely,
poliovirus and human rhinovirus block the nuclear
import of proteins via the Imp-a/b1 and Imp-b2
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pathways by viral-mediated proteolytic cleavage of spe-
cific Nups [21,177–183]. Other viruses inhibit the
nuclear import of the STAT proteins that are known to
be key regulators of the cell anti-virus response. Fur-
thermore, the severe acute respiratory syndrome
(SARS) virus disrupts the nuclear import of STAT1 by
tethering the tyrosine-phosphorylated STAT1–Imp-a/
Imp-b complex to endoplasmic reticulum/Golgi mem-
branes [184–187]. Yet another way exploited by viruses
to prevent STAT1 nuclear localization is to bind viral
proteins to import receptors. The Ebola virus VP24
protein binds Imp-a to block its interaction with phos-
phorylated STAT1 and hnRNP C1/C2 [188–190]. The
L1 protein of the human papilloma virus type 11 binds
Imp-b2/b3 and disrupts cargo import. Encephalomyo-
carditis virus exerts its inhibitory effect on the nuclear
protein import of infected cells via its L protein that
hyper-phosphorylates Nups and binds Ran [191–193].
In addition herpes viruses and HIV promote viral
mRNA export by reprogramming the cellular transport
pathways. The HIV-1 Rev protein facilitates nuclear
export of unspliced or partially spliced viral mRNAs
through the Rev-responsive element, an RNA signature
within these viral mRNAs [85,194,195]. As a result,
Rev-bound viral RNA binds to CRM1 and RanGTP
and is transported through the NPC.
Conclusions
The nuclear transport processes within our cells are
governed by several types of protein–protein interac-
tions (e.g. adaptor protein–cargo, adaptor protein–
transport receptor, transport receptor–cargo, transport
receptor–Ran, transport receptor–Nup), yet only one
enzymatic reaction occurs, namely the hydrolysis of
GTP by Ran GTPase. While pharmacological target-
ing of protein–protein interactions has historically
been considered challenging, the development of
nuclear export inhibitors proves the viability of this
approach. Therapeutic agents that attempt to normal-
ize or to target protein localization are aimed at vari-
ous regulatory components within the transport
process, including the upstream regulatory compo-
nents, the cargo proteins, the transport receptors, the
Ran regulators and the NPC itself. In some cases,
compounds have been developed to successfully influ-
ence subcellular protein distribution in disease states,
including CRM1 and Imp-a/b inhibitors. Continued
and intensified research efforts aimed at better under-
standing the nuclear transport mechanisms, and how
they relate to pathogenesis, will probably reveal the
identity of novel targets for the treatment of cancer
and to subvert viral infections.
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